Search clinical trials for: Galantamine 12 mg

Total 11377 results

Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease

Alzheimer's Disease

Japan
University of Aarhus
Aarhus University Hospital

Completed

Does the Bioactive Substance in Coffee, Cafestol, Have Preventive Properties on Type-2-diabetes? (Acute Substudy)

Obesity, Abdominal

Denmark
Repros Therapeutics Inc.

Completed

Comparison of Two Formulations of Proellex for Oral Administration

Healthy

United States
Actavis Inc.

Completed

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions

Healthy

Canada
Actavis Inc.

Completed

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Repros Therapeutics Inc.

Completed

Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200

Uterine Fibroids
INTRuST, Post-Traumatic Stress Disorder - Traumatic...
U.S. Army Medical Research and Development Command

Terminated

Cognitive REmediation After Trauma Exposure Trial = CREATE Trial (CREATE)

Traumatic Brain Injury | Posttraumatic Stress Disorder

United States
Boehringer Ingelheim

Completed

Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type

Alzheimer Disease
Serpin Pharma, LLC
University of Virginia

Recruiting

SP16 as a Therapeutic for COVID-19 Induced ARDS

Pneumonia | SARS CoV 2 Infection

United States
MedImmune LLC

Completed

Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas

Relapsed/Refractory Aggressive B-cell Lymphomas

United States
Otonomy, Inc.

Completed

OTO-104 for Meniere's Disease

Meniere's Disease

United States
University of Texas Southwestern Medical Center
GlaxoSmithKline

Recruiting

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

AL Amyloidosis | Amyloidosis

United States
Sunovion

Completed

Dasotraline SEP360-105 Pediatric PK/PD Study

Pediatric Attention Deficit Hyperactivity Disorder

United States
Watson Pharmaceuticals

Completed

Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis

Hyperhidrosis

United States
GlaxoSmithKline

Completed

A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects (DEMAND I)

Muscular Dystrophies

France, United States
Repros Therapeutics Inc.

Completed

Extension of Study ZPV-200

Uterine Fibroids

United States
Janssen Research & Development, LLC

Completed

A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma

Lymphoma, T-Cell, Cutaneous

France, United Kingdom, Spain, Portugal, United States, Germany
Fundacion Clinic per a la Recerca Biomédica

Unknown

Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients (EARLY-HEP-C)

Hepatitis C | HIV

Spain
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic Fibrosis

Cystic Fibrosis

Spain
Yale University
National Institute on Drug Abuse (NIDA)

Completed

A Study to Help People Quit Smoking.

Nicotine Dependence

United States
Ardea Biosciences, Inc.

Completed

RDEA3170 PK/PD Study

Gout

United States
Serum Institute of India Pvt. Ltd.
PPD

Completed

Safety Study of Dengushield in Healthy Adults

Dengue | Phase 1

Australia
Mundipharma Research Limited

Completed

A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.

Pain

United Kingdom
Merck Sharp & Dohme LLC

Terminated

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) (APECS)

Alzheimer's Disease | Amnestic Mild Cognitive Impairment | Prodromal Alzheimer's Disease
Estetra

Completed

E4/DRSP Single and Multiple Dose PK and Early QT Study

Contraception
Samsung Medical Center
Janssen Korea, Ltd., Korea

Completed

Characteristics of Treatment Responders to Galantamine

Dementia

Korea, Republic of
Amgen

Completed

Pegfilgrastim PBPC Mobilization Study

Lymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Oncology | Hematology
Ludwig-Maximilians - University of Munich

Unknown

Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)

Alzheimer's Disease

Germany
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH); Massachusetts General Hospital

Completed

Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder

Bipolar Disorder

United States
The University of Texas Health Science Center,...

Completed

Subarachnoid Hemorrhage Recovery And Galantamine (SAHRANG)

Subarachnoid Hemorrhage

United States
Pfizer

Withdrawn

Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia

Dyslipidemia | Hypercholesterolemia
Virginia Commonwealth University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Interleukin-1 Blockade in Recently Decompensated Heart Failure (RED-HART)

Heart Failure

United States
Hal Chapman
Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaborators

Recruiting

Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

Idiopathic Pulmonary Fibrosis

United States
USDA, Western Human Nutrition Research Center
University of California, Davis

Completed

Vitamin A Bioavailability in Lactating Women With Marginal Vitamin A Status

Vitamin A Deficiency

Bangladesh
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

Dementia, Vascular
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease

Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia

Frontotemporal Dementia | Pick Complex
Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.

Alzheimer Disease
Providence Health & Services

Completed

α-TEA in Advanced Cancer

Metastatic Sarcoma | Metastatic Carcinoma | Metastatic Lymphoma

United States
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation

Dementia | Alzheimer Disease
Parkinson's Disease and Movement Disorders Center
Ortho-McNeil Neurologics, Inc.

Terminated

Safety Study of Galantamine in Tic Disorders

Tourette's Syndrome | Motor Tic Disorder | Vocal Tic Disorder

United States
AbbVie (prior sponsor, Abbott)

Terminated

A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain

Diabetic Neuropathic Pain

United States
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease

Alzheimer's Disease
University of Georgia
DSM Nutritional Products, Inc.

Completed

Macular Pigment and Glare Disability (MP-GD)

Vision, Entoptic

United States
Jenny Craig, Inc.

Completed

Effect of 14:10 Time-Restricted Eating on Body Weight and Metabolic Markers

Time Restricted Feeding

United States
Stanford University

Active, not recruiting

Patient-Reported Outcome Measurement in Heart Failure Clinic (PRO-HF)

Heart Failure

United States
Merck Sharp & Dohme LLC

Completed

Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001) (GIANT)

Schizophrenia
Xian-Janssen Pharmaceutical Ltd.

Completed

A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

Pharmacokinetics
Bristol-Myers Squibb

Completed

Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)

Alzheimer Disease

United States

Search clinical trials for: Galantamine 12 mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations